Tafamidis: Capsule 61 mg; Vyndamax® Acalabrutinib: Capsule 100 mg; Calquence® Page last updated: 13 November 2020 Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 1937KB) Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 743KB)